fda glp 1 green list FDA's List: A Step in the Right Direction for Patient Safety Follow up from the new

Brighten: I love that

The revolutionary compounds have been demonstrated to disperse and fade existing Melanin as well as hinder the development of new Melanin

10.1128/mcb.16.9.4604 42 FratantonioD.VirgiliF.ZucchiA.LambrechtsK.LatronicoT.LafreP.et al (2021)

Current Neuropharmacology 2016 Sikiri et al

But, as always happens with big pharma blockbusters, the research community is busy exploring other possible applications for this class of compounds, with clinical trials underway or forming in cardiovascular disease, chronic kidney disease and obstructive sleep apnea

They have recently introduced Noom Med, a personalized clinical support program built on top of their existing psychology-based program